Goodwin Procter represented AlloVir, and Latham & Watkins represented the underwriters in the offering.AlloVir, Inc. (Nasdaq: ALVR) announced the pricing of an underwritten public offering of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
